- The trend backdrop is active with a 29-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
BEZ
LSE
Week ended 07 Aug 2026
Weekly Investor Report
Beazley plc · Financial Services · Insurance - Specialty
Latest close
1,290 GBP
0.0%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 3.2% above the Trend Line and sits at 99.0% of its 52-week range. The latest completed week returned 0.0%, after a 0.3% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers. The latest news-sentiment score is 51/100. Near-term considerations: price is close to its 52-week high.
Setup score
70
out of 100
Latest Close
1,290 GBP
7 Aug 2026
1W Return
0.0%
latest completed week
4W Return
0.3%
short-term follow-through
12W Return
0.8%
quarterly tape
Trend Breadth
55.8%
29 of 52 weeks active
Volume Ratio
1.6x
vs 13-week average
- No major top-level risk cluster is currently dominant.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.0%
Latest completed week; four-week move 0.3%.
Indicator stack
76/60
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
51/100
7 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 3.2% above the Trend Line and sits at 99.0% of its 52-week range. The latest completed week returned 0.0%, after a 0.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.8812-week average 0.93
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure1/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.88Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 0.3% over four weeks, 0.8% over 12 weeks, and 42.5% over one year. The current trend has remained active for 29 consecutive weeks.
Performance by holding period
Active trend streak29 weeks
Active weeks in one year29
Trend breadth55.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.04Latest activity-pressure read.
Pressure change111.9%Four-week change in activity pressure.
Leadership11.10Latest relative-leadership reading.
RS change-33.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Dec 2025
Field coverage 82%
Model confidence 65%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength99/100Blend of value, momentum, and quality. Underlying universe rank 2; rank 1 is best.
Value94/100Relative valuation strength. Underlying universe rank 7; rank 1 is best.
Quality92/100Profitability and accounting quality. Underlying universe rank 9; rank 1 is best.
Momentum94/100Medium-term price momentum. Underlying universe rank 7; rank 1 is best.
Growth11/100Revenue and earnings growth. Underlying universe rank 90; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 8.4x Price divided by trailing earnings.
- Price / sales
- 7.3x Market value relative to trailing revenue.
- EV / EBITDA
- 5.6x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 18.0% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- - Gross profit retained from each unit of revenue.
- Operating margin
- 112.2% Operating profit retained from revenue.
- Free-cash-flow margin
- 117.9% Free cash flow generated from revenue.
- Return on invested capital
- 21.6% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 4.4% Latest one-year revenue growth.
- EPS growth
- -13.7% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 118.1% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 5/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 1.9% Cash dividends relative to market value.
- Buyback yield
- 7.0% Net share repurchases relative to market value.
- Shareholder yield
- 8.9% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- -0.6x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment51/100
Weighted news tone is neutral across 7 relevant articles.
3 positive · 4 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-0.4%Distance below the 52-week high.
13-week volatility0.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 267 weeks finished lower.
Best week+3.9%Week of 27 Feb.
Worst week-1.8%Week of 20 Mar.
Latest week+0.0%Week of 7 Aug.
Shape of recent returns
Strong gains0
Modest gains14
Flat weeks5
Modest losses7
Sharp losses0
Recent vol0.1%13-week weekly-return volatility.
Base vol6.4%52-week weekly-return volatility.
Up/down split30/17Count of positive and negative weeks in the 52-week window.
Average skew3.0% / -2.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorGB Financial Services
4-week rank65 / 100
Group average2.1%
Trend breadth60.0%
Trend60.0%active weekly trend signals
MD68.0%positive activity pressure
RS53.0%positive relative leadership
Four-week leaders
IndustryGB Insurance - Specialty
4-week rank1 / 2
Group average-3.1%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD100.0%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape72/100
Trend, activity pressure, participation, and risk combine to a 72/100 tape read.
Indicator analysis70/100Latest 12-week confirmation: trend 12/12, activity pressure 1/12, relative leadership 12/12.
Activity pressure 0.88; No reversal markers Factors94/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 9 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment51/100Weighted news tone is neutral across 7 relevant articles.
Form 8.3 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1,290 GBP | 0.0% | 1,251 GBP | 841.9 GBP | 0.04 | 11.10 | 17.9M | On |
| 31 Jul 2026 | 1,290 GBP | -0.2% | 1,235 GBP | 837.1 GBP | -0.01 | 11.81 | 12.1M | On |
| 24 Jul 2026 | 1,293 GBP | 0.4% | 1,220 GBP | 832.1 GBP | -0.09 | 13.85 | 16.7M | On |
| 17 Jul 2026 | 1,288 GBP | 0.1% | 1,204 GBP | 827.3 GBP | -0.23 | 15.28 | 7.7M | On |
| 10 Jul 2026 | 1,286 GBP | -0.1% | 1,189 GBP | 822.8 GBP | -0.36 | 16.74 | 15.3M | On |
| 3 Jul 2026 | 1,288 GBP | 0.2% | 1,173 GBP | 818.1 GBP | -0.57 | 15.32 | 1.2M | On |
| 26 Jun 2026 | 1,284 GBP | 0.0% | 1,157 GBP | 813.5 GBP | -0.67 | 17.30 | 4.5M | On |
| 19 Jun 2026 | 1,284 GBP | 0.1% | 1,140 GBP | 809.0 GBP | -0.68 | 19.27 | 5.3M | On |
| 12 Jun 2026 | 1,283 GBP | 0.0% | 1,126 GBP | 804.4 GBP | -0.57 | 18.28 | 5.8M | On |
| 5 Jun 2026 | 1,283 GBP | 0.2% | 1,114 GBP | 799.9 GBP | -0.49 | 19.87 | 6.7M | On |
| 29 May 2026 | 1,281 GBP | -0.0% | 1,101 GBP | 795.3 GBP | -0.37 | 19.51 | 18.1M | On |
| 22 May 2026 | 1,282 GBP | 0.1% | 1,089 GBP | 791.1 GBP | -0.34 | 19.26 | 19.4M | On |
| 15 May 2026 | 1,280 GBP | 0.1% | 1,077 GBP | 786.8 GBP | -0.09 | 22.66 | 16.4M | On |
| 8 May 2026 | 1,279 GBP | 0.2% | 1,063 GBP | 782.5 GBP | 0.19 | 22.59 | 12.4M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.